ReviewAmerican journal of obstetrics and gynecology2012
Benefits of influenza vaccination during pregnancy for pregnant women.
Review in American journal of obstetrics and gynecology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women.Vaccine · 2016Guideline
- Influenza vaccine awareness and uptake patterns among women of reproductive age in Pudong New Area: A community-based cross-sectional study.Human vaccines & immunotherapeutics · 2026Article
- New Zealand school children's perspectives on influenza: listening to young voices in respiratory health.BMC pediatrics · 2025Article
- Immunogenicity and memory B-cell potency induced by an inactivated COVID-19 vaccine in pregnant women.Molecular medicine (Cambridge, Mass.) · 2025Article
- COVID-19 and influenza vaccine uptake among pregnant women in national cohorts of England and Wales.NPJ vaccines · 2024Article
- Association Between Influenza Vaccination and SARS-CoV-2 Infection.American journal of reproductive immunology (New York, N.Y. : 1989) · 2024Article
- Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats.NPJ vaccines · 2023Article
- Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine.Reproductive toxicology (Elmsford, N.Y.) · 2021Article
- Article
- Immunobiology of Acute Chorioamnionitis.Frontiers in immunology · 2020Review
- Sex differences in vaccine-induced humoral immunity.Seminars in immunopathology · 2019Review
- Tolerability of trivalent inactivated influenza vaccine among pregnant women, 2015.BMC pregnancy and childbirth · 2018Article
- Seasonal influenza vaccination in pregnant women: knowledge, attitudes, and behaviors in Italy.BMC infectious diseases · 2017Article
- Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.PloS one · 2017Article
- Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.Frontiers in medicine · 2017Article
- [Role of health professionals of sexual health and reproduction clinics in the influenza vaccination in pregnant women].Atencion primaria · 2016Article
- Influenza Vaccine Requirements in Pregnant Women.Journal of obstetrics and gynaecology of India · 2016Review
- Optimizing benefits of influenza virus vaccination during pregnancy: potential behavioral risk factors and interventions.Vaccine · 2014Review
- Influenza vaccination in pregnant women: a systematic review.ISRN preventive medicine · 2013Article
- The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014.Public health reports (Washington, D.C. : 1974)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Influenza vaccination is a cornerstone of influenza prevention efforts among pregnant women. Prior to 2005, data from studies conducted on pregnant women were limited, with much of the supporting evidence coming from influenza vaccine studies conducted among nonpregnant, age-matched populations. Since 2005, however, an increasing number of studies have demonstrated the safety and immunogenicity of influenza vaccine for pregnant women, including evidence of maternal transfer of antibody. In addition, the clinical benefit of influenza vaccination, both for the mother and infant, was demonstrated in a landmark randomized clinical trial conducted in Bangladesh. Additional randomized clinical trials with laboratory-confirmed influenza as the primary outcome are underway in countries without a current influenza vaccination program, but such trials are unlikely to be conducted in the United States or other countries that already recommend the vaccination of pregnant women. However, current evidence supports the safety and immunogenicity of inactivated influenza vaccine and its effectiveness in reducing the risk of influenza-related illness among pregnant women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.